A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer
Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the valu...
Saved in:
Published in | PloS one Vol. 17; no. 9; p. e0274282 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
San Francisco
Public Library of Science
19.09.2022
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery. The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek's funnel figure. The literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95%CI (0.62, 0.71)], specificity pooled-value was 0.71 [95%CI (0.67, 0.72)], PLR pooled-value was 2.37 [95%CI [1.52, 3.71]), NLR pooled into 0.53 [95%CI (0.36, 0.78)], DOR pooled into 4.97 [95%CI (2.11, 11.72)], AUC was 0.7395. Peripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis. |
---|---|
AbstractList | Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery.OBJECTIVECirculating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery.The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek's funnel figure.METHODThe PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek's funnel figure.The literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95%CI (0.62, 0.71)], specificity pooled-value was 0.71 [95%CI (0.67, 0.72)], PLR pooled-value was 2.37 [95%CI [1.52, 3.71]), NLR pooled into 0.53 [95%CI (0.36, 0.78)], DOR pooled into 4.97 [95%CI (2.11, 11.72)], AUC was 0.7395.RESULTThe literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95%CI (0.62, 0.71)], specificity pooled-value was 0.71 [95%CI (0.67, 0.72)], PLR pooled-value was 2.37 [95%CI [1.52, 3.71]), NLR pooled into 0.53 [95%CI (0.36, 0.78)], DOR pooled into 4.97 [95%CI (2.11, 11.72)], AUC was 0.7395.Peripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis.CONCLUSIONPeripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis. Objective Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery. Method The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek’s funnel figure. Result The literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95%CI (0.62, 0.71)], specificity pooled-value was 0.71 [95%CI (0.67, 0.72)], PLR pooled-value was 2.37 [95%CI [1.52, 3.71]), NLR pooled into 0.53 [95%CI (0.36, 0.78)], DOR pooled into 4.97 [95%CI (2.11, 11.72)], AUC was 0.7395. Conclusion Peripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis. Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery. The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek's funnel figure. The literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95%CI (0.62, 0.71)], specificity pooled-value was 0.71 [95%CI (0.67, 0.72)], PLR pooled-value was 2.37 [95%CI [1.52, 3.71]), NLR pooled into 0.53 [95%CI (0.36, 0.78)], DOR pooled into 4.97 [95%CI (2.11, 11.72)], AUC was 0.7395. Peripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis. Objective C irculating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery. Method The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021. Relevant literature searches and data extraction were performed independently by two reviewers. The quality assessment was performed using the QUADAS2 scale developed by the Cochrane collaboration. The heterogeneity was checked using the Spearman correlation coefficient and the Cochran-Q test in the Meta-Disc1.4 software. Subgroup analysis was used to explore the source of heterogeneity. Considering that all the included papers were clinical studies with clinical heterogeneity, random effect model was adopted for analysis. And the sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curves of CTCs, in monitoring recurrence and metastasis after CRC, were calculated. The publication bias of the included studies was assessed using Deek’s funnel figure. Result The literature included a total of 13 articles, comprising 1788 cases, and the overall quality of the literature was high. After summing up the indicators, the sensitivity pooled-value of the peripheral blood CTCs to monitor the recurrence and metastasis value of CRC after CRC was 0.67 [95% CI (0.62, 0.71)], specificity pooled-value was 0.71 [95% CI (0.67, 0.72)], PLR pooled-value was 2.37 [95% CI [1.52, 3.71]), NLR pooled into 0.53 [95% CI (0.36, 0.78)], DOR pooled into 4.97 [95% CI (2.11, 11.72)], AUC was 0.7395. Conclusion Peripheral blood CTCs have a moderate monitoring value for recurrence and metastasis after CRC; CTCs detected one week after surgery may be more correlated with recurrence and metastasis. |
Audience | Academic |
Author | Li, Zhongyu Cui, Ning Hao, Tengteng Yi, Kangjun Wu, Yu Wu, Jiao Yang, Jingyan Li, Liusheng Zou, Jianhua |
AuthorAffiliation | 2 Graduate School of Beijing University of Chinese Medicine, Beijing, China 1 Oncology Department of Xiyuan Hospital, China Academy of Chinese Medical Science Haidian District, Beijing, China VA Boston Healthcare System, Harvard Medical School (Brigham and Women’s Hospital), UNITED STATES |
AuthorAffiliation_xml | – name: 1 Oncology Department of Xiyuan Hospital, China Academy of Chinese Medical Science Haidian District, Beijing, China – name: 2 Graduate School of Beijing University of Chinese Medicine, Beijing, China – name: VA Boston Healthcare System, Harvard Medical School (Brigham and Women’s Hospital), UNITED STATES |
Author_xml | – sequence: 1 givenname: Jiao surname: Wu fullname: Wu, Jiao – sequence: 2 givenname: Zhongyu surname: Li fullname: Li, Zhongyu – sequence: 3 givenname: Jianhua surname: Zou fullname: Zou, Jianhua – sequence: 4 givenname: Liusheng surname: Li fullname: Li, Liusheng – sequence: 5 givenname: Ning surname: Cui fullname: Cui, Ning – sequence: 6 givenname: Tengteng surname: Hao fullname: Hao, Tengteng – sequence: 7 givenname: Kangjun surname: Yi fullname: Yi, Kangjun – sequence: 8 givenname: Jingyan surname: Yang fullname: Yang, Jingyan – sequence: 9 givenname: Yu orcidid: 0000-0002-3409-4581 surname: Wu fullname: Wu, Yu |
BookMark | eNqNk9tq3DAQhk1JaZJt36BQQ6G0F7vVwZbtXhRC6CEQCPR0K2bl8a4WWdpI8tLc9skrZ92SDaEUGWyPvv8fzaA5zY6ss5hlzylZUF7Rtxs3eAtmsU3hBWFVwWr2KDuhDWdzwQg_uvN9nJ2GsCGk5LUQT7JjLiijdVmeZL_O8h4jzCFZ3QQdctflcY35DsyA44_SXg0GorarPA6987lCY0Kubd47q6Pz487Whei26BO3w9yjGrxHqzAH294mCOnZuytnXAIimFxBQvzT7HEHJuCz6T3Lvn_88O388_zy6tPF-dnlXAnRxLlCJYq2K1TNEbFhtao4xUKwlhdEIGNsCXVZlVA0Lalx2ZVdtUQFRHSiLgjhs-zF3ndrXJBT-4JkFS0rwVlas-xiT7QONnLrdQ_-RjrQ8jbg_EqCj1oZlGzZtsCalhMORUkVpONhU1MslzVvKE1e76dsw7LHVqGNHsyB6eGO1Wu5cjvZFHUhyiYZvJ4MvLseMETZ6zD2Hiy6YTp3Qwo2oi_voQ9XN1ErSAVo27mUV42m8qyiNReCpgsyyxYPUGm12GuV7lqnU_xA8OZAkJiIP-MKhhDkxdcv_89e_ThkX91h1wgmroMzQ9TOhkOw2IPKuxA8dn-bTIkcR-VPN-Q4KnIalSR7d0-mdITRPRWszb_FvwFIQR17 |
CitedBy_id | crossref_primary_10_3390_cancers16132316 crossref_primary_10_1002_jso_27400 crossref_primary_10_1097_MD_0000000000036819 crossref_primary_10_1186_s12943_024_02063_2 |
Cites_doi | 10.1186/1471-2482-10-27 10.1038/bjc.2012.595 10.3390/cancers12113308 10.1200/JCO.2011.40.9615 10.21037/tcr.2020.01.37 10.1186/1471-2407-14-976 10.1038/sj.bjc.6605651 10.1634/theoncologist.2012-0048 10.1016/j.cell.2017.01.026 10.1016/j.athoracsur.2004.09.040 10.1097/01.SLA.0000055223.27623.F3 10.1097/SLA.0b013e318142d918 10.1016/j.ejca.2021.09.004 10.1016/j.ctrv.2017.02.002 10.1016/j.omto.2021.05.005 10.1186/s12885-017-3704-8 10.1038/s41523-021-00319-4 10.1245/s10434-006-9289-0 10.3322/caac.21156 10.7326/0003-4819-155-8-201110180-00009 10.1245/s10434-008-9961-7 10.1007/s13277-013-0752-9 10.1002/bjs.5526 10.7150/jca.30512 10.1038/srep24517 10.1016/j.ejca.2020.11.025 10.1080/17843286.2016.1177264 10.1016/S0304-3835(02)00157-X 10.1200/JCO.2005.01.6071 10.1097/EDE.0000000000000857 10.1186/s40880-019-0368-6 10.1158/1078-0432.CCR-20-2589 10.1186/s40364-021-00326-4 10.1155/2014/712827 10.1038/bjc.2011.40 10.1186/s12885-015-1218-9 10.3390/biomedicines9091179 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Public Library of Science 2022 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Wu et al 2022 Wu et al |
Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Wu et al 2022 Wu et al |
DBID | AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0274282 |
DatabaseName | CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1932-6203 |
ExternalDocumentID | 2715763232 oai_doaj_org_article_2bdda29d303a451cacece981e5b83911 PMC9484659 A718366105 10_1371_journal_pone_0274282 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; grantid: 2017YFC1700606 – fundername: ; grantid: CI2021A01803 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI RC3 7X8 5PM PUEGO AAPBV ABPTK BBAFP N95 |
ID | FETCH-LOGICAL-c669t-cec64df4c83eee928c731e462d3406e222ba8575a49d08ebf5f7beca06f684003 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sun Jan 01 07:45:44 EST 2023 Wed Aug 27 00:54:14 EDT 2025 Thu Aug 21 18:39:11 EDT 2025 Mon Jul 21 10:44:10 EDT 2025 Fri Jul 25 11:31:14 EDT 2025 Tue Jun 17 20:45:50 EDT 2025 Tue Jun 10 20:38:18 EDT 2025 Fri Jun 27 05:02:03 EDT 2025 Fri Jun 27 04:43:45 EDT 2025 Thu May 22 21:16:57 EDT 2025 Tue Jul 01 01:18:34 EDT 2025 Thu Apr 24 23:06:44 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c669t-cec64df4c83eee928c731e462d3406e222ba8575a49d08ebf5f7beca06f684003 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 JZ and LL also contributed equally to this work. Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0002-3409-4581 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0274282 |
PMID | 36121855 |
PQID | 2715763232 |
PQPubID | 1436336 |
PageCount | e0274282 |
ParticipantIDs | plos_journals_2715763232 doaj_primary_oai_doaj_org_article_2bdda29d303a451cacece981e5b83911 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9484659 proquest_miscellaneous_2715790429 proquest_journals_2715763232 gale_infotracmisc_A718366105 gale_infotracacademiconefile_A718366105 gale_incontextgauss_ISR_A718366105 gale_incontextgauss_IOV_A718366105 gale_healthsolutions_A718366105 crossref_primary_10_1371_journal_pone_0274282 crossref_citationtrail_10_1371_journal_pone_0274282 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-19 |
PublicationDateYYYYMMDD | 2022-09-19 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-19 day: 19 |
PublicationDecade | 2020 |
PublicationPlace | San Francisco |
PublicationPlace_xml | – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationYear | 2022 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | N Vermeer (pone.0274282.ref007) 2017; 54 D Nesteruk (pone.0274282.ref021) 2014; 2014 X Bessa (pone.0274282.ref019) 2003; 237 Y Jun-hui (pone.0274282.ref044) 2020; 29 ZG Özkan (pone.0274282.ref009) 2021 S Sadahiro (pone.0274282.ref023) 2007; 14 W Dong (pone.0274282.ref043) 2017; 55 T Koch (pone.0274282.ref001) 2021 D Sargent (pone.0274282.ref033) 2005; 23 M Hayashi (pone.0274282.ref031) 2010; 10 O Rui (pone.0274282.ref032) 2017 A Bortolini Silveira (pone.0274282.ref012) 2021; 7 C Dive (pone.0274282.ref010) 2017; 168 RP Jones (pone.0274282.ref034) 2021; 144 RD Madoff (pone.0274282.ref006) 2012; 30 X Ma (pone.0274282.ref017) 2018; 29 L Benhaim (pone.0274282.ref036) 2021; 159 H Yu (pone.0274282.ref042) 2020; 20 Y Uen (pone.0274282.ref025) 2008; 15 D Wang (pone.0274282.ref029) 2019; 10 J-H Yu (pone.0274282.ref030) 2020; 9 H Xie (pone.0274282.ref004) 2021; 27 J Sastre (pone.0274282.ref041) 2012; 17 O Akin (pone.0274282.ref008) 2012; 62 S Ito (pone.0274282.ref022) 2002; 183 P Gazzaniga (pone.0274282.ref028) 2013; 34 R Siegel (pone.0274282.ref005) 2020; 70 G Peach (pone.0274282.ref039) 2010; 102 X Huang (pone.0274282.ref045) 2014; 14 H Qian (pone.0274282.ref011) 2021; 22 D Kust (pone.0274282.ref015) 2016; 71 T Allen-Mersh (pone.0274282.ref020) 2007; 94 P Whiting (pone.0274282.ref016) 2011; 155 Y Uen (pone.0274282.ref024) 2007; 246 W Tsai (pone.0274282.ref037) 2016; 6 R Feng (pone.0274282.ref002) 2019; 39 M Jiang (pone.0274282.ref014) 2021; 9 C Jones (pone.0274282.ref018) 2005; 79 C Yang (pone.0274282.ref038) 2017; 17 LB Callesen (pone.0274282.ref035) 2022 E Osterman (pone.0274282.ref003) 2020; 12 X Huang (pone.0274282.ref040) 2015; 15 C Lu (pone.0274282.ref026) 2011; 104 W Cieślikowski (pone.0274282.ref013) 2021; 9 C Lu (pone.0274282.ref027) 2013; 108 |
References_xml | – volume: 10 start-page: 27 year: 2010 ident: pone.0274282.ref031 article-title: Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis publication-title: BMC surgery doi: 10.1186/1471-2482-10-27 – volume: 108 start-page: 791 issue: 4 year: 2013 ident: pone.0274282.ref027 article-title: Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer publication-title: British journal of cancer doi: 10.1038/bjc.2012.595 – volume: 12 issue: 11 year: 2020 ident: pone.0274282.ref003 article-title: Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It? publication-title: Cancers doi: 10.3390/cancers12113308 – volume: 30 start-page: 1738 issue: 15 year: 2012 ident: pone.0274282.ref006 article-title: Defining quality in colon cancer surgery publication-title: J Clin Oncol doi: 10.1200/JCO.2011.40.9615 – volume: 9 start-page: 1487 issue: 3 year: 2020 ident: pone.0274282.ref030 article-title: Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection publication-title: Translational Cancer Research doi: 10.21037/tcr.2020.01.37 – volume: 14 start-page: 976 year: 2014 ident: pone.0274282.ref045 article-title: Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis publication-title: BMC Cancer doi: 10.1186/1471-2407-14-976 – volume: 70 start-page: 145 issue: 3 year: 2020 ident: pone.0274282.ref005 article-title: Colorectal cancer statistics, 2020 publication-title: CA: a cancer journal for clinicians – volume: 102 start-page: 1327 issue: 9 year: 2010 ident: pone.0274282.ref039 article-title: Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review publication-title: British journal of cancer doi: 10.1038/sj.bjc.6605651 – volume: 17 start-page: 947 issue: 7 year: 2012 ident: pone.0274282.ref041 article-title: Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study publication-title: The oncologist doi: 10.1634/theoncologist.2012-0048 – year: 2021 ident: pone.0274282.ref001 article-title: Bilateral Oophorectomy and Rate of Colorectal Cancer: A Prospective Cohort Study publication-title: International journal of cancer – volume: 168 start-page: 742 issue: 4 year: 2017 ident: pone.0274282.ref010 article-title: SnapShot: Circulating Tumor Cells publication-title: Cell doi: 10.1016/j.cell.2017.01.026 – volume: 79 start-page: 16 issue: 1 year: 2005 ident: pone.0274282.ref018 article-title: Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests publication-title: The Annals of thoracic surgery doi: 10.1016/j.athoracsur.2004.09.040 – volume: 237 start-page: 368 issue: 3 year: 2003 ident: pone.0274282.ref019 article-title: Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure publication-title: Annals of surgery doi: 10.1097/01.SLA.0000055223.27623.F3 – volume: 246 start-page: 1040 issue: 6 year: 2007 ident: pone.0274282.ref024 article-title: Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection publication-title: Annals of surgery doi: 10.1097/SLA.0b013e318142d918 – volume: 159 start-page: 24 year: 2021 ident: pone.0274282.ref036 article-title: Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS) publication-title: Eur J Cancer doi: 10.1016/j.ejca.2021.09.004 – volume: 54 start-page: 87 year: 2017 ident: pone.0274282.ref007 article-title: Colorectal cancer screening: Systematic review of screen-related morbidity and mortality publication-title: Cancer treatment reviews doi: 10.1016/j.ctrv.2017.02.002 – year: 2021 ident: pone.0274282.ref009 article-title: Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up: FDG PET in recurrent colorectal CA publication-title: Ann Nucl Med. – volume: 22 start-page: 72 year: 2021 ident: pone.0274282.ref011 article-title: Progress and application of circulating tumor cells in non-small cell lung cancer publication-title: Molecular therapy oncolytics doi: 10.1016/j.omto.2021.05.005 – volume: 17 issue: 1 year: 2017 ident: pone.0274282.ref038 article-title: Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review publication-title: BMC Cancer doi: 10.1186/s12885-017-3704-8 – volume: 7 start-page: 115 issue: 1 year: 2021 ident: pone.0274282.ref012 article-title: Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer publication-title: NPJ breast cancer doi: 10.1038/s41523-021-00319-4 – volume: 14 start-page: 1092 issue: 3 year: 2007 ident: pone.0274282.ref023 article-title: Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer publication-title: Annals of surgical oncology doi: 10.1245/s10434-006-9289-0 – volume: 62 start-page: 364 issue: 6 year: 2012 ident: pone.0274282.ref008 article-title: Advances in oncologic imaging: update on 5 common cancers publication-title: CA Cancer J Clin doi: 10.3322/caac.21156 – volume: 155 start-page: 529 issue: 8 year: 2011 ident: pone.0274282.ref016 article-title: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies publication-title: Annals of internal medicine doi: 10.7326/0003-4819-155-8-201110180-00009 – volume: 15 start-page: 2120 issue: 8 year: 2008 ident: pone.0274282.ref025 article-title: Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection publication-title: Annals of surgical oncology doi: 10.1245/s10434-008-9961-7 – volume: 34 start-page: 2507 issue: 5 year: 2013 ident: pone.0274282.ref028 article-title: Circulating tumor cells in high-risk nonmetastatic colorectal cancer publication-title: Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine doi: 10.1007/s13277-013-0752-9 – volume: 94 start-page: 96 issue: 1 year: 2007 ident: pone.0274282.ref020 article-title: Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma publication-title: The British journal of surgery doi: 10.1002/bjs.5526 – volume: 10 start-page: 4552 issue: 19 year: 2019 ident: pone.0274282.ref029 article-title: Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer publication-title: Journal of Cancer doi: 10.7150/jca.30512 – volume: 6 start-page: 24517 year: 2016 ident: pone.0274282.ref037 article-title: Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients publication-title: Scientific reports doi: 10.1038/srep24517 – volume: 144 start-page: 368 year: 2021 ident: pone.0274282.ref034 article-title: Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis publication-title: Eur J Cancer doi: 10.1016/j.ejca.2020.11.025 – volume: 71 start-page: 235 issue: 4 year: 2016 ident: pone.0274282.ref015 article-title: Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker publication-title: Acta clinica Belgica doi: 10.1080/17843286.2016.1177264 – volume: 183 start-page: 195 issue: 2 year: 2002 ident: pone.0274282.ref022 article-title: Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler publication-title: Cancer letters doi: 10.1016/S0304-3835(02)00157-X – year: 2022 ident: pone.0274282.ref035 article-title: Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis publication-title: Br J Cancer – volume: 55 start-page: 765 issue: 10 year: 2017 ident: pone.0274282.ref043 article-title: Detection and clinical significance of circulating tumor cells in patients with colorectal carcinoma publication-title: Chinese Journal of Surgery – volume: 23 start-page: 8664 issue: 34 year: 2005 ident: pone.0274282.ref033 article-title: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology doi: 10.1200/JCO.2005.01.6071 – volume: 29 start-page: 821 issue: 6 year: 2018 ident: pone.0274282.ref017 article-title: Performance of Between-study Heterogeneity Measures in the Cochrane Library publication-title: Epidemiology (Cambridge, Mass) doi: 10.1097/EDE.0000000000000857 – volume: 39 start-page: 22 issue: 1 year: 2019 ident: pone.0274282.ref002 article-title: Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? publication-title: Cancer communications (London, England) doi: 10.1186/s40880-019-0368-6 – volume: 27 start-page: 141 issue: 1 year: 2021 ident: pone.0274282.ref004 article-title: Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence publication-title: Clinical cancer research: an official journal of the American Association for Cancer Research doi: 10.1158/1078-0432.CCR-20-2589 – year: 2017 ident: pone.0274282.ref032 publication-title: Correlation Clinical Study of Preoperatie Neurtrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Colon Cancer Patients with the Lymph Metastasis: Guangxi Medical University – volume: 9 start-page: 85 issue: 1 year: 2021 ident: pone.0274282.ref014 article-title: Detection and clinical significance of circulating tumor cells in colorectal cancer publication-title: Biomarker research doi: 10.1186/s40364-021-00326-4 – volume: 2014 start-page: 712827 year: 2014 ident: pone.0274282.ref021 article-title: Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data publication-title: BioMed research international doi: 10.1155/2014/712827 – volume: 104 start-page: 1178 issue: 7 year: 2011 ident: pone.0274282.ref026 article-title: Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse publication-title: British journal of cancer doi: 10.1038/bjc.2011.40 – volume: 15 start-page: 202 year: 2015 ident: pone.0274282.ref040 article-title: Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer publication-title: BMC cancer doi: 10.1186/s12885-015-1218-9 – volume: 20 start-page: 317 issue: 1 year: 2020 ident: pone.0274282.ref042 article-title: Significant diagnostic value of circulating tumour cells in colorectal cancer publication-title: Oncology letters – volume: 29 start-page: 230 issue: 3 year: 2020 ident: pone.0274282.ref044 article-title: Prognostic Value of Circulating Tumor Cells in Stage Colorectal Cancer Undergoing Curative Resection:Seventy-three Cases Report publication-title: China Cancer – volume: 9 issue: 9 year: 2021 ident: pone.0274282.ref013 article-title: Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management publication-title: Biomedicines doi: 10.3390/biomedicines9091179 |
SSID | ssj0053866 |
Score | 2.4322264 |
Snippet | Objective Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have... Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive... Objective C irculating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have... |
SourceID | plos doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | e0274282 |
SubjectTerms | Biology and Life Sciences Biomarkers Blood Cancer Care and treatment Cohort analysis Colorectal cancer Colorectal carcinoma Complications Correlation coefficient Correlation coefficients Data search Development and progression Disc1 protein Heterogeneity Likelihood ratio Literature reviews Medical prognosis Medicine and Health Sciences Meta-analysis Metastases Metastasis Methods Monitoring Mortality Patient outcomes Peripheral blood Quality assessment Quality control Quality of life Relapse Research and Analysis Methods Risk factors Sensitivity analysis Subgroups Surgery Tumor cells Tumor markers Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDI_QO3FBjA-tMCAgJODQrW36leMDMQ0kQAKGdqvS1NmetNdWbd8_wF-OneRVq4Q0DhzbuGlqO7aTxj8z9lqDLEtQJpSoPmEqjQnRr2dhBglk0Jg4aigb-cvX_Ow8_XyRXdwo9UVnwhw8sGPcSVI3jUpkg6ZWpVmslQbqP4asRt_usnrR5-0XU84G4yzOc58oJ4r4xMvluO9aOLZ_J8tk4YgsXv9slVf9dTcuQs7lgckbHuj0PrvnQ0e-dkM-YHegfcAO_OQc-VuPIP3uIfu95luYVKg84gjvDMdAjxOyN9CF3gza1u1qL_m023YDpw38kW9avrWTnHb7eE-gGz04bHA-0M68zQ3kqm3sCzCy9L0T9jXZThyfJj0aHrHz048_P5yFvthCqPNcTiGyNU8bk-pSAIBMSl2IGNI8aQT6fMAwolZUzVOlsolKqE1mCpS_inJDeDGReMxWLbL3kPE0NzXl79ZCFClEKMGyQGFBXKAslJYBE3vOV9ojkVNBjOvK_l4rcEXiOFqRvCovr4CF81O9Q-K4hf49CXWmJRxtewO1q_LaVd2mXQF7QSpRuaTU2RpUa3TpAkObKAvYK0tBWBotHda5VLtxrD59-_UPRD--L4jeeCLTITtwLC5BAr-JMLoWlEcLSrQIetF8SAq858pYJUWMy0qBwTM-uVfqvze_nJupUzqA10K38zSSopeAFYvJsGDwsqXdXFnAcplilJvJJ_9DIk_Z3YQyUKiKhzxiq2nYwTOMC6f6uTUBfwDKkGYB priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELagXLggloe2ywIGIQGH7ObhPHxCBVEWJEACFu0tcpxxqbRNQpL-AX45M44TiISAY-uJ4867tucbxp5okFkGyngS1ccT0hgP43rsxRBCDKUJ_JKqkd9_SM7OxbuL-MJtuHXuWuXoE62jLmtNe-SnYRpgahxhAvCi-e5R1yg6XXUtNK6yawFGGrrSla3fjJ4YbTlJXLlclAanTjonTV3BiT2jzMJZOLKo_ZNvXjSXdTdLPOfXJn-LQ-ub7IZLIPlqkPgBuwLVLXbgTLTjzxyO9PPb7MeK76BXnnK4I7w2HNM9TvjeQB_0ttW2e1e14f1-V7ectvE7vq34zpo67fnxhqA3GhgQwnlL-_O2QpCrqrQvwPzSzU4I2ORBcX2atKm9w87Xr7-8OvNcywVPJ4nsPQ06EaUROosAQIaZTqMARBKWEUZ-wGSiUNTTUwlZ-hkUJjYpaoHyE0OoMX50ly0qZO8h4yIxBVXxFlGUCvDDoszSAqcNUpSF0nLJopHzuXZ45NQW4zK3h2wp_i8ZOJqTvHInryXzpqeaAY_jH_QvSagTLaFp2y_qdpM748xxbaUKZYnhXIk40ArZgDocQIwLxmiwZA9JJfKhNHXyCfkKA3uECY4fL9ljS0GIGhVd2dmofdflbz9-_Q-iz59mRE8dkamRHbiWoUwCfxMhdc0oj2eU6Bf0bPiQFHjkSpf_siB8clTqPw8_moZpUrqGV0G9dzSScpglS2fGMGPwfKTafrOw5VJgrhvLo7-__B67HlKFCXXpkMds0bd7uI95X188sMb9E_BiXLs priority: 102 providerName: ProQuest |
Title | A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer |
URI | https://www.proquest.com/docview/2715763232 https://www.proquest.com/docview/2715790429 https://pubmed.ncbi.nlm.nih.gov/PMC9484659 https://doaj.org/article/2bdda29d303a451cacece981e5b83911 http://dx.doi.org/10.1371/journal.pone.0274282 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELaW7oULYnloC0sxCAk4pMrb8QGh7qplQdoFLRT1FjmOXSq1SUhaCS4c-OXMOG5EpOVxsdR67Lrj8cz4Md8Q8kwqniRKaIeD-Dgh19oBux45kfJVpHLtuTlGI19cxufz8N0iWhyQfc5Wy8Dm2q0d5pOa1-vxt6_fX8OCf2WyNjBv32hclYUam7vHBJTyIdgmhjkNLsLuXgFWt7m9RK_FiX03sMF0f-qlZ6wMpn-nuQfVumx6bmn_UeVvVmp2m9yy7iWdtPJwRA5UcYcc2QXc0BcWZfrlXfJzQjdqKxxhUUloqSk4gxTRvxV-kKtamtxexZJud5uypnjI39BVQTdGEeCJIK0QmKNSLX44rfH03sQPUlHk5gfA-7S9Iz426lcYn0RZq--R-Wz66ezcsQkZHBnHfOtIJeMw16FMAqUU9xPJAk-FsZ8H4BcocDUygRk_RchzN1GZjjQDGRFurBFTxg3uk0EB7D0mNIx1hjG-WRCwULl-licsg249BnMhJB-SYM_5VFq0ckyasU7NFRyDXUvL0RTnK7XzNSRO16pq0Tr-QX-Kk9rRIta2-aKsl6lduimMLRc-z8HYizDypAA2gIR7KoIBg60YkscoEmkbuNppjHQCZj8A98eNhuSpoUC8jQIf9CzFrmnSt-8__wfRx6se0XNLpEtgB4ylDaKA_4Q4Xj3Kkx4laA3Zqz5GAd5zpUl95sHWMwAHG1ruhfr66iddNXaKj_QKVe4sDUcPZ0hYbzH0GNyvKVZfDKg5D8ETjviDvw_7IbnpY_wJ5vDgJ2SwrXfqEXiF22xEbrAFgzI587CcvRmRw9Pp5YerkTlnGRlFgOWP6S9n7Gp9 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWcoALYnloCwtrEAg4ZDcP5-EDQuVRWvaBBLurvRnHcUqlbRKSVogrP4jfyIzjFCIh4LLH1hPHGY9nvsSebwh5pDRPEi1zh4P5OIznuQNxPXRC7etQZ7nnZpiNfHgUTU7Yu7PwbIP86HJh8Fhl5xONo85Khd_I9_zYA2gcAAB4UX1xsGoU7q52JTRas9jX377CK1vzfPoa5vex74_fHL-aOLaqgKOiiC8dpVXEspypJNBacz9RceBpFvlZAMFNQ7xMJZatlIxnbqLTPMxjeFDpRjkSo7gB9HuJXGYBRHLMTB-_7Tw_-I4osul5QeztWWvYrcpC75o90cTvhT9TJWAdCwbVedn0gG7_mOZvcW98nVyzgJWOWgvbJBu6uEE2rUto6FPLW_3sJvk-ogu9lI60PCe0zCnAS4p84hp_qHmtTLWwYkaXq0VZU9w2aOi8oAvjWvAbI62Q6qPSLSM5rXE_wGQkUllk5gaAZ23vyLiNHhvGp9B661vk5EIm4zYZFKDeLUJZlKeYNZwGQcy066dZEqfQrRfDXEjFhyToNC-U5T_HMhznwmzqxfAe1GpU4HwJO19D4qyvqlr-j3_Iv8RJXcsie7f5o6xnwjoDAWPLpM8zgA-ShZ6SoAZYM54OYcAQfYZkB01CtKmwax8kRgAkAgBUbjgkD40EMngUeERoJldNI6bvT_9D6OOHntATK5SXoA4YS5uWAc-EzGA9ye2eJPgh1WveQgPutNKIXysWruyM-s_ND9bN2Cke-yt0ubIyHDHTkMS9xdBTcL-lmH82NOmcAbYO-Z2_33yHXJkcHx6Ig-nR_l1y1cfsFqwQwrfJYFmv9D3AnMv0vlnolHy6aM_yE58emkc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIiEuiPJQFwo1CAQc0s078QGhpWXVUigIKOrNOI69rNRNQrIrxJWfxa9jxnECkRBw6XHXE8eZd2LPN4Q8kIqlqRLaYaA-Tsi0diCuR06kfBWpXHtujtXIr4_jg5Pw5Wl0ukF-dLUweKyy84nGUeelxG_kEz_xIDUOIAGYaHss4u3-7Fn1xcEOUrjT2rXTaFXkSH37Cq9vzdPDfZD1Q9-fvfiwd-DYDgOOjGO2cqSScZjrUKaBUor5qUwCT4WxnwcQ6BTEzkxgC0sRstxNVaYjncBDCzfWCJLiBjDvBXIxCZIUbSzd64-XgB-JY1uqFyTexGrGblUWatfsj6b-IBSajgF9XBhVZ2UzSHqHRzZ_i4Gzq-SKTV7ptNW2TbKhimtk07qHhj62GNZPrpPvU7pUK-EIi3lCS00h1aSILa7wh1zU0nQOK-Z0tV6WNcUthIYuCro0bga_N9IKYT8q1aKT0xr3Bkx1IhVFbm4Aua2dHdG30XvD-iRqcn2DnJyLMG6SUQHs3SI0jHWGFcRZECShcv0sT5MMpvVAUp6QbEyCjvNcWix0bMlxxs0GXwLvRC1HOcqLW3mNidNfVbVYIP-gf45C7WkRydv8UdZzbh0Dh7Xlwmc5pBIijDwpgA1gP56KYMEQicZkB1WCt2WxvT_iU0gqAkiu3GhM7hsKRPMo0C7mYt00_PDNx_8gev9uQPTIEukS2AFraUs04JkQJWxAuT2gBJ8kB8NbqMAdVxr-y3rhyk6p_zx8rx_GSfEIYKHKtaVhmD-NSTIwhgGDhyPF4rOBTGch5NkRu_X3m--QS-BT-KvD46Pb5LKPhS7YLIRtk9GqXqs7kH6usrvGzin5dN6O5ScbY55I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+meta-analysis+of+the+value+of+circulating+tumor+cells+in+monitoring+postoperative+recurrence+and+metastasis+of+colorectal+cancer&rft.jtitle=PloS+one&rft.au=Wu%2C+Jiao&rft.au=Li%2C+Zhongyu&rft.au=Zou%2C+Jianhua&rft.au=Li%2C+Liusheng&rft.date=2022-09-19&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=9&rft.spage=e0274282&rft_id=info:doi/10.1371%2Fjournal.pone.0274282&rft.externalDocID=A718366105 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |